Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11,240 GBX | -0.09% | +3.60% | +6.32% |
10:12am | AstraZeneca: Voydeya approved in the EU as a treatment for HPN | CF |
08:29am | AstraZeneca Obtains EU Approval for Voydeya as Add-on Treatment for Rare Blood Disease | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.32% | 215B | |
+25.46% | 659B | |
+25.80% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+7.60% | 210B | |
-6.26% | 200B | |
-8.79% | 149B | |
-5.59% | 146B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : COVID-19 Vaccine Gets Emergency Use Approval in Brazil